What are asset-based biotechs?

Asset-based biotechs—those that are developing more traditional assets for specific indications—accounted for the remaining third of VC funding in 2022. McKinsey analysis grouped asset-based companies according to their primary therapeutic area of focus or that of the lead asset.

What is a biotech company?

Until recently, biotech companies tended to be founded with a focus on a single technology or biological pathway.

What currency does biotechnology assets SA use?

Data as of Dec 18 2023. Currency figures normalised to Biotechnology Assets SA's reporting currency: Euro EUR Biotechnology Assets SA (BST:MCE) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.

What is a biotech portfolio?

For biotech companies, the portfolio model represents an alternative to an acquisition or IPO. Companies have traditionally funded maturing pipelines through a combination of public investment and industry partnerships.